Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-132185
Filing Date
2024-12-27
Accepted
2024-12-27 17:15:10
Documents
1
Period of Report
2024-12-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2431988-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2431988-1_4seq1.xml 4 8363
  Complete submission text file 0001104659-24-132185.txt   10010
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Issuer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O QUOIN PHARMACEUTICALS, LTD. AZRIELI CENTER, ROUND TOWER, 30TH FLOOR TEL AVIV L3 6701101
Business Address
Culverwell Anthony James (Reporting) CIK: 0001693548 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37846 | Film No.: 241586319